Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Los términos de búsqueda han de ser en inglés.

Partners for research project and product development sought for detection, validation and commercialization of epigenetic-marker based in-vitro diagnostics (IVD) testing in oncology indications with high unmet medical need

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TODE20200910001
Publicado:
21/09/2020
Caducidad:
22/09/2021
Resumen:
German biotech SME specialized in molecular biology and cancer diagnostics developed a fast and reliable diagnostic test based on epigenetic changes (DNA methylation) which are characteristic for cancer cells and applicable for early detection. Seeks medical partners for research and product development projects, related to epigenetic-marker based in-vitro diagnostics (IVD) testing in defined oncology indications with a high unmet medical need, for research and technical cooperation agreements.

Details

Tittle:
Partners for research project and product development sought for detection, validation and commercialization of epigenetic-marker based in-vitro diagnostics (IVD) testing in oncology indications with high unmet medical need
Summary:
German biotech SME specialized in molecular biology and cancer diagnostics developed a fast and reliable diagnostic test based on epigenetic changes (DNA methylation) which are characteristic for cancer cells and applicable for early detection. Seeks medical partners for research and product development projects, related to epigenetic-marker based in-vitro diagnostics (IVD) testing in defined oncology indications with a high unmet medical need, for research and technical cooperation agreements.
Description:
A young German biotech SME with strong involvement in regional and national health clusters plans to widen its international scope. The company is specialized in molecular biology and cancer diagnostics and has developed a fast and reliable diagnostic test based on epigenetic changes (DNA methylation) which are characteristic for cancer cells. These highly informative biomarkers validated in clinical trials and applicable for early detection of cervical cancer. Corresponding marker sets for head-and-neck tumor and ovarian cancer are also validated.

The SME sized company is operating in ISO 13485 certified development and production labs. The team is developing epigenetic cancer tests since more than 10 years and is marketing an epigenetic triage test for clarification of unclear Pap or HPV screening results in the course of cervical cancer screening. The company is ready to develop a cost-effective Point-of-Care (POC) cervical cancer diagnostics test based on its proprietary cervical cancer diagnostic and prognostic biomarkers.
The company is developing diagnostic and prognostic kits in further indications based on epigenetic markers and is open for joint research -Y- development projects to identify, validate and develop proprietary diagnostic tests in further oncology indications with a high unmet medical need.

The company is looking for strategic partners in product development of epigenetic-marker based diagnostic tests in to-be-defined oncology indications or may also join research consortia in joint national and international projects under research and technical cooperation agreements.
Seeking medical partners for research and product development projects, related to epigenetic-marker based in-vitro diagnostics (IVD) testing in defined oncology indications with a high unmet medical need, for research and technical cooperation agreements. Partners are welcome from industry and research.
Advantages and Innovations:
Proprietary epigenetic markers, developed by the company in connection with a reknown university hospital since 2008, have various advantages:
- They are specifically linked to carcinogenesis of tumor cells - contrary to the current screening tests, which are in the case of cervical cancer linked to HPV infection.
- They detect stable and robust DNA cell regulation mechanisms.
- Easy to use -Y- objective read-out: Markers detected with established PCR-based technology.
- Fast turn-around: Time to result < 6 h, hands-on time < 2h
- Robust -Y- economic: No specific requirements for the material used in the test
- Diagnostic assays from the company show very high sensitivity and specificity both in screening as well as in triage testing settings.

Expansion with lower-end market price products to emerging countries offers additional upsides. The company is working on proof-of-concept studies for the implementation of relevant biomarkers into point-of-care diagnostic tests, besides diagnostic tests for established real-time PCR platforms of large providers such as Roche Dx (Cobas Z480) and Life Technologies (Abi7500).
Stage of Development:
Concept stage
IPs:
Secret Know-how,Patents granted,Trade Marks
CommeR Statunts Regarding IPR Status:
Patents already granted for EU, Canada, US and Japan; further territories via second patent family, currently in the PCT-phase (priority Sep 2017). Decade-long experience and first-mover advantage for the development of robust, reliable and CE-IVD marked diagnostic tests based on epigenetic markers (incl. bisulfite conversion and real-time PCR).

Partner sought

Type and Role of Partner Sought:
Seeking medical partners for research and product development projects, related to epigenetic-marker based in-vitro diagnostics (IVD) testing in defined oncology indications with a high unmet medical need, for research and technical cooperation agreements. Partners are welcome from industry and research.

Client

Type and Size of Client:
Industry SME 11-49
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
German

Keywords

Technology Keywords:
06001003 Citología, cancerología, oncología
06001005 Diagnósticos, diagnosis
06002007 Ensayos in vitro, experimentos
06001002 Investigaciones clínicas, ensayos
06001012 Investigaciones médicas